Vanguard Capital Management’s Phio Pharmaceuticals PHIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$97.1K Hold
94,262
– – ﹤0.01% 3851
2026
Q2
$96.6K Buy
94,262
+14,409
+18% +$16.4K ﹤0.01% 3881
2026
Q1
$97.4K Buy
+79,853
New +$91.1K ﹤0.01% 3867

Other funds holding PHIO

Vanguard Capital Management's PHIO Position: Q3 2026 in Review

Vanguard Capital Management held its Phio Pharmaceuticals (PHIO) position steady in Q3 2026 at 94,262 shares worth $97.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3851.

Vanguard Capital Management first reported a position in PHIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $97.4K in Q1 2026. 26 funds tracked by Wall St. Rank hold PHIO as of Q3 2026.

  • Vanguard Capital Management held 94,262 shares of Phio Pharmaceuticals worth $97.1K as of Q3 2026.
  • Vanguard Capital Management left its Phio Pharmaceuticals share count unchanged in Q3 2026.
  • Phio Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3851 holding.
  • Vanguard Capital Management first reported a position in Phio Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Phio Pharmaceuticals position peaked at $97.4K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.